Igor G. Bakulin

Saint Petersburg, SPE, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Safety Management of Incretin-Based Obesity Therapy: Expert Consensus on the Use of Semaglutide and Tirzepatide

Safety Management of Incretin-Based Obesity Therapy: Expert Consensus on the Use of Semaglutide and Tirzepatide

Journal: Problemy endokrinologii

Published: May 08, 2026

Reclassification of the diagnosis in inflammatory bowel disease based on a retrospective analysis

Reclassification of the diagnosis in inflammatory bowel disease based on a retrospective analysis

Journal: Terapevticheskii arkhiv

Published: April 17, 2026

Effectiveness and Safety of First-Line Empirical Eradication Therapy with Rebamipide: Results from the European Registry on Helicobacter pylori Management (Hp-EuReg).

Effectiveness and Safety of First-Line Empirical Eradication Therapy with Rebamipide: Results from the European Registry on Helicobacter pylori Management (Hp-EuReg).

Journal: Antibiotics (Basel, Switzerland)

Published: April 15, 2026

The opportunities to improve therapy adherence in patients with overweight and obesity in real clinical practice

The opportunities to improve therapy adherence in patients with overweight and obesity in real clinical practice

Journal: Problemy endokrinologii

Published: February 06, 2026

A global consensus on the critical care management of acute-on-chronic liver failure patients: the APASL ACLF Beijing Position Paper.

A global consensus on the critical care management of acute-on-chronic liver failure patients: the APASL ACLF Beijing Position Paper.

Journal: Hepatology international

Published: November 26, 2025

Higher doses of Bismuth and antibiotics do not improve H. pylori treatment effectiveness: results from the Hp-EuReg.

Higher doses of Bismuth and antibiotics do not improve H. pylori treatment effectiveness: results from the Hp-EuReg.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: November 18, 2025

Higher Doses of Bismuth and Antibiotics Do Not Improve Helicobacter pylori Treatment Effectiveness: Results From the European Registry on Helicobacter pylori Management.

Higher Doses of Bismuth and Antibiotics Do Not Improve Helicobacter pylori Treatment Effectiveness: Results From the European Registry on Helicobacter pylori Management.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: November 18, 2025

Russian Cross-disciplinary Consensus on the diagnosis and treatment of spondyloarthritis associated with inflammatory bowel diseases

Russian Cross-disciplinary Consensus on the diagnosis and treatment of spondyloarthritis associated with inflammatory bowel diseases

Journal: Terapevticheskii arkhiv

Published: February 22, 2025

Clinical portraits of patients with gluten-associated diseases (according to the North-West Center for the Treatment of Patients with Gluten-Associated Diseases)

Clinical portraits of patients with gluten-associated diseases (according to the North-West Center for the Treatment of Patients with Gluten-Associated Diseases)

Journal: Terapevticheskii arkhiv

Published: October 18, 2024

Patients With Non-Obstructive Coronary Artery Disease and Polyvascular Disease. Sub-Analysis of the Real-World Registry KAMMA (Clinical Registry on Patient Population With Polyvascular Disease in the Russian Federation and Eurasian Countries).

Patients With Non-Obstructive Coronary Artery Disease and Polyvascular Disease. Sub-Analysis of the Real-World Registry KAMMA (Clinical Registry on Patient Population With Polyvascular Disease in the Russian Federation and Eurasian Countries).

Journal: Kardiologiia

Published: April 18, 2024

Inflammatory bowel diseases: Transformation of representations. A review

Inflammatory bowel diseases: Transformation of representations. A review

Journal: Terapevticheskii arkhiv

Published: December 26, 2023

Comparative Analysis of the Efficacy of Different Regimens of 12 Months Rifaximin-Alfa Therapy in Patients with Liver Cirrhosis and Minimal Hepatic Encephalopathy.

Comparative Analysis of the Efficacy of Different Regimens of 12 Months Rifaximin-Alfa Therapy in Patients with Liver Cirrhosis and Minimal Hepatic Encephalopathy.

Journal: Diagnostics (Basel, Switzerland)

Published: August 17, 2023

Showing 1-12 of 57

Last Updated: 09/26/2026